跳至主要内容
临床试验/NCT01865591
NCT01865591Unknown早期 1 期

A Clinical Trial for the Assessment of Safety and Efficacy of the UltraSOUND Mediated InTerVentional Treatment of Resistant Hypertension

Sound Interventions, Inc.2 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2012年4月1日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
发起方
入组人数
30
试验地点
2
主要终点
Major adverse events

研究概览

简要总结

The aim of this study is to assess the potential therapeutic benefit of catheter-based renal sympathetic denervation using therapeutic unfocussed ultrasound in a single-arm feasibility trial.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Uncontrolled hypertension (defined as SBP ≥ 140 mmHg during 24Hr Ambulatory BP monitoring)
  • Current treatment with ≥ 3 anti-hypertensive drugs (including at least one diuretic)
  • Renal artery diameter ≥5mm by digital angiography
  • Accessibility of renal vasculature

排除标准

  • Estimated GFR < 45
  • Type 1 Diabetes
  • Known renovascular abnormalities (eg, renal artery stenosis, previous renal artery stenting or angioplasty)

研究组 & 干预措施

Renal denervation

Experimental

Subjects are treated with unfocussed ultrasound-based renal denervation and are maintained on baseline anti-hypertensive medications.

干预措施: Ultrasound-based Renal Denervation (Device)

结局指标

主要结局

Major adverse events

时间窗: 30 days

All cause death, renal artery occlusion, renal artery stenosis, renal infarction and/or renal failure

次要结局

  • Adverse events and device complications(12 months)
  • Change from baseline in creatinine(6 months)
  • Change from baseline in office blood pressure measurement(30 days, 3 months, 6 months, 9 months, 12 months)
  • Change from baseline in ambulatory 24-hour blood pressure measurement(6 months, 12 months)
  • Change from baseline in renal artery dimensions(30 days)

研究者

发起方
Sound Interventions, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验